— Know what they know.
Not Investment Advice

LIMNW NASDAQ

Liminatus Pharma, Inc. Warrants
1W: +27.3% 1M: -16.2% 3M: -42.6% YTD: +52.9% 1Y: -85.8%
$0.05
+0.00 (+11.01%)
 
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $1.3M mcap · 5M float · 0.109% daily turnover · Short 76% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-07-17
Earliest Filing
2026-02-09
Latest Filing
investor: 2

Counterparties (Filed by LIMNW)

2 relationships

Companies named in LIMNW's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Clear Street LLC — investor Settlement agreement involving surrender and cancellation of warrants in exchange for common stock 2026-02-09 View
Alta Partners, LLC — investor Settlement agreement involving surrender and cancellation of warrants in exchange for common stock 2025-07-17 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-29 Delisting Notice; Regulation FD; Exhibits View
2026-08-18 Delisting Notice; Bylaws Amendment; Regulation FD; Exhibits View
2026-08-04 Shareholder Vote View
2026-07-30 Other Events; Exhibits View
2026-07-24 Delisting Notice; Other Events; Exhibits View
2026-07-06 Material Agreement; Acquisition/Disposition; Unregistered Equity Sales; Bylaws Amendment; Exhibits Agreement Acquisition View
2026-06-03 Material Agreement; Unregistered Equity Sales; Other Events; Exhibits Agreement View
2026-05-27 Delisting Notice; Exhibits View
2026-05-20 Material Agreement; Exhibits Agreement View
2026-03-04 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2026-02-18 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2026-02-09 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2026-01-26 Notice of Delisting or Transfer View
2025-11-25 Notice of Delisting or Transfer View
2025-08-25 Notice of Delisting or Transfer; Financial Statements and Exhibits View
2025-08-14 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-07-17 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities Agreement View
2025-07-11 Departure/Election of Directors; Appointment of Officers View
2025-07-03 Other Events View
2025-06-24 Regulation FD Disclosure; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms